Comparison of distal perfusion timing in peripheral VA-ECMO patients
Not Applicable
Recruiting
- Conditions
- Symptoms, signs and abnormal clinical and laboratory findings, NEC
- Registration Number
- KCT0008043
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Adult patients in refractory cardiogenic shock and peripheral VA-ECMO support with informed consent
Exclusion Criteria
1. Unwilling or unable to obtain informed consent by the participant or substitute decision maker
2. Patients who are currently pregnant, postpartum period within 30 days or breast-feeding
3. VA-ECMO application for causes other than cardiogenic shock
4. Severe coagulopathy
5. End-staged cancer diseases
6. Irreversible cerebral dysfunction
7. Irreversible limb ischemia requiring interventional procedures or surgery at the time of VA-ECMO
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ower limb ischemia requiring interventional procedures or surgery or resulting in neurological sequelae
- Secondary Outcome Measures
Name Time Method Mortality;Successful VA-ECMO weaning;Major bleeding;Systemic thromboembolism;Complication related with distal perfusion catheter;Time to distal perfusion catheterization;ICU days, Total hospital days